top of page
Executive Spotlights

Lilly to acquire DICE Therapeutics for approximately $2.4B

Indianapolis and South San Francisco, CA, June 20, 2023 (PRNewswire) -- Lilly announced the acquisition of DICE Therapeutics, a biopharmaceutical company known for its groundbreaking DELSCAPE technology platform. The strategic move aims to bolster Lilly's efforts in developing novel oral therapeutic candidates to address the urgent medical needs of patients suffering from chronic immunological conditions, marking a significant advancement in the field.

Read full article here.

Recent Posts

See All

Radiant Vision Systems Appoints new CEO

Redmond, WA, July 1, 2024 (Radiant) -- Radiant Vision Systems has appointed Stone Jiang as their new CEO, succeeding Doug Kreysar who is retiring. Jiang, previously the Executive Vice President and

Orion and Merck Secure $1.63B Agreement

Rahway, NJ, July 1, 2024 (Business Wire) -- Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, and Orion Corporation ("Orion") have agreed to convert their co-development and co-commercial


Life Science Headlines
bottom of page